Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if UNCY is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
19 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 13
80 filers reported a long position in UNCY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $6.6M | 1.4M | +3,836.7% |
| Nantahala Capital Management, LLC | $6.6M | 1.4M | +49.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $5M | 1.1M | +32% |
| Octagon Capital Advisors LP | $4.7M | 1M | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $2.6M | 564K | +176.8% |
| Vivo Capital, LLC | $2.6M | 550K | -69.3% |
| MARSHALL WACE, LLP | $2.6M | 547.9K | +253.6% |
| Logos Global Management LP | $2.2M | 473.6K | Unchanged |
| STATE STREET CORP | $2.1M | 450.2K | +462.5% |
| Diametric Capital, LP | $1.8M | 374.1K | +365.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.